Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd.
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is...
advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:RVV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Apr 18, 2023 7:24pm
$RVV - Update !
#Bucillamine https://ca.finance.yahoo.com/news/revive-therapeutics-provides-phase-3-224400249.html
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 18, 2023 6:44pm
New Press Release - Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
TORONTO, April 18, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today an update on...
read article.
Q Precious & Battery Metals to Drill Initial 1000 metres at La Corne and McKenzie East Gold Projects, Quebec
posted Apr 18, 2024 9:00am by
Q Precious & Battery Metals Corp
-
|
The Company is planning for an initial 1,000 metres of diamond drilling scheduled for mid- June 2024, with VMS targets on the La Corne South project at proposed depths ranging from 50 to 300 metres below surface as modelled by the EM survey and noted in historic drilling. TMC Geophysique completed deep-penetrating Pulse-EM -Time Domain Electromagnetic (TDEM) surveying on the claims that targeted ...read more
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Apr 18, 2023 4:47pm
Revive Therapeutics - Informal shareholder meeting
https://www.reddit.com/r/RVVTF/comments/12qmj8o/informal_shareholder_meeting/
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Apr 13, 2023 4:02pm
Reddit - Letter sent to Revive BoD
https://www.reddit.com/r/RVVTF/comments/12kpawg/letter_sent_to_the_bod/
(0)
•••
GenevaC
X
View Profile
View Bullboard History
Post by
GenevaC
on Apr 13, 2023 4:24am
Kevin Harrington Discusses FSD Pharma
I believe this new product will aid society in reducing the
...more
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Apr 10, 2023 7:48pm
Pfizer Caught Covering Up Data on Waning Immunity !
#Bucillamine https://slaynews.com/news/pfizer-caught-covering-up-data-waning-immunity/?utm_source=mailpoet&utm_medium=email&utm_campaign=daily-newsletter
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Apr 05, 2023 10:35am
InflaRx's anti-inflammation drug despite phase 3 miss !
#Bucillamine Interesting Article ! https://www.fiercepharma.com/pharma/fda-authorizes-inflarxs-anti-inflammation-drug-most-serious-covid-despite-phase-3-miss
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Apr 04, 2023 9:00pm
Reddit - Response received for presentation request
https://www.reddit.com/r/RVVTF/comments/12bnva8/response_received_for_presentation_request/
(7)
•••
90guppy
X
View Profile
View Bullboard History
Comment by
90guppy
on Apr 03, 2023 9:19am
RE:$RVV Advances MDMA Transdermal Patch Development !
HAHAHAHAHAHAH!
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Apr 03, 2023 7:29am
$RVV Advances MDMA Transdermal Patch Development !
https://ca.finance.yahoo.com/news/revive-therapeutics-advances-mdma-transdermal-110000273.html
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 03, 2023 7:00am
New Press Release - Revive Therapeutics Advances MDMA Transdermal Patch Development with Purchase of MDMA Supply from PharmAla Biotech
Purchased MDMA supply from PharmAla Biotech for upcoming IND-enabling studies Finalizing product and clinical development plans for upcoming studies and potential commercial opportunitiesTORONTO, April 03, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB...
read article.
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Apr 02, 2023 3:22pm
$RVV - Reddit Post !
https://www.reddit.com/r/RVVTF/comments/12882tj/presentation_request_submitted/
(158)
•••
MyAli4s
X
View Profile
View Bullboard History
Comment by
MyAli4s
on Mar 28, 2023 11:23pm
RE:RE:RE:Johnny Lambo & MF - JL bought more shares today !
lol
(158)
•••
MyAli4s
X
View Profile
View Bullboard History
Comment by
MyAli4s
on Mar 28, 2023 11:22pm
RE:RE:Johnny Lambo & MF - JL bought more shares today !
Yup
(42)
•••
cool888
X
View Profile
View Bullboard History
Comment by
cool888
on Mar 28, 2023 9:21pm
RE:RE:$RVV Provides Update on Psilocybin Clinical Study
sorry, wrong post
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Asset Sale Allows Biotech Company to Refocus on the High Value Dermatological Market
Positive PEA for Uranium-Vanadium Deposit After-tax NPV 8%: $227.7 million with IRR: 38.9%
Fokus Mining Welcomes Luc Gervais To Its Board Of Directors
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Q Precious & Battery Metals Contracts First Class Drilling for Quebec Projects
Why the Tonopah Gold Project is One to Watch
Targeting Nevada and Ontario for the Critical Minerals Supply Chain